Bleeding prevention in von Willebrand disease type 3

Bleeding prevention in von Willebrand disease type 3 refers to prophylactic management aimed at averting spontaneous, surgical, and post-traumatic hemorrhagic events in patients with the rarest and most severe form of this inherited hematologic disorder Affected individuals face a severe, lifelong bleeding phenotype characterized by frequent mucocutaneous hemorrhage as well as deep-tissue bleeding, such as recurrent hemarthroses and muscle hematomas

Bleeding prevention in von Willebrand disease type 3 refers to prophylactic management aimed at averting spontaneous, surgical, and post-traumatic hemorrhagic events in patients with the rarest and most severe form of this inherited hematologic disorder

Characterized by an autosomal recessive inheritance, type 3 von Willebrand disease results from a virtually complete absence of von Willebrand factor, which secondarily causes a profound deficiency in coagulation factor VIII This dual defect impairs both primary platelet-mediated hemostasis and secondary intrinsic coagulation pathway activity

Characterized by an autosomal recessive inheritance, type 3 von Willebrand disease results from a virtually complete absence of von Willebrand factor, which secondarily causes a profound deficiency in coagulation factor VIII This dual defect impairs both primary platelet-mediated hemostasis and secondary intrinsic coagulation pathway activity Affected individuals face a severe, lifelong bleeding phenotype characterized by frequent mucocutaneous hemorrhage as well as deep-tissue bleeding, such as...

This dual defect impairs both primary platelet-mediated hemostasis and secondary intrinsic coagulation pathway activity